BioLife Solutions, Inc. (NASDAQ:BLFS) announced its earnings results on Thursday. The medical equipment provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.03, Bloomberg Earnings reports. BioLife Solutions had a negative return on equity of 58.57% and a negative net margin of 52.10%. The business had revenue of $2.96 million for the quarter, compared to the consensus estimate of $2.60 million.

BioLife Solutions (BLFS) opened at $5.91 on Friday. BioLife Solutions has a 1-year low of $1.50 and a 1-year high of $7.53.

Separately, Maxim Group upped their price objective on BioLife Solutions from $7.00 to $8.00 and gave the stock a “buy” rating in a report on Friday.

COPYRIGHT VIOLATION WARNING: “BioLife Solutions, Inc. (BLFS) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS” was posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Earnings History for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.